Fireside chat // Scaling food biomanufacturing: What will reach commercial production?

28 Oct 2026
Main Auditorium
Main Stage

Food biomanufacturing is moving from breakthrough science to a race for commercial viability. Across Asia, new production hubs are emerging — but which technologies can truly scale? This session explores the role of policy, investment, infrastructure and manufacturing strategy in moving beyond the pilot plant, alongside how R&D teams are balancing biological functionality, formulation needs, cost and customer demand. From precision fermentation and cell-based production to natural bioactives and next-generation fibres, where is the clearest path to commercial impact?

Host
Eshan Samaranayake
Eshan Samaranayake, Founder, BETTER BIOECONOMY and Investor - BETTER BITE VENTURES, Singapore
Speakers
Didier Toubia
Didier Toubia, Co-Founder & CEO - ALEPH FARMS, Isreal
Mirte Gosker
Mirte Gosker, CEO - GOOD FOOD INSTITUTE APAC, Singapore
Shakthi M. Nagappan
Shakthi M. Nagappan, Chairman, PREFERCO and Advisor (Lifesciences) - GOVERNMENT OF TELENGANA, India